Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-21-006991
Filing Date
2021-05-13
Accepted
2021-05-13 07:30:27
Documents
3
Period of Report
2021-05-13

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20210513x6k.htm 6-K 17308
2 EX-99.1 tmb-20210513xex99d1.htm EX-99.1 78115
3 GRAPHIC tmb-20210513xex99d1001.jpg GRAPHIC 5123
  Complete submission text file 0001558370-21-006991.txt   103621
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 21917198
SIC: 2836 Biological Products, (No Diagnostic Substances)